Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-12 5:29 pm Sale | 2026-09-30 | 13G | HELUS PHARMA INC HELP | Integrated Core Strategies (US) LLC | 1,018,972 1.400% | -1,810,921![]() (-63.99%) | Filing History |
| 2026-11-10 5:27 pm Purchase | 2026-11-06 | 13G | RXSIGHT INC RXST | Integrated Core Strategies (US) LLC | 2,191,247 5.200% | 49,195![]() (+2.30%) | Filing History |
| 2026-11-09 6:01 pm Sale | 2026-09-30 | 13G | STEPSTONE GROUP INC STEP | Integrated Core Strategies (US) LLC | 3,203,652 3.900% | -2,415,846![]() (-42.99%) | Filing History |
| 2026-11-03 5:51 pm Sale | 2026-09-30 | 13G | CYTEK BIOSCIENCES INC CTKB | Integrated Core Strategies (US) LLC | 7,281,488 5.600% | -2,056,522![]() (-22.02%) | Filing History |
| 2026-11-02 6:02 pm Sale | 2026-09-30 | 13G | CATALYST ACQUISITION CORP. USD CATL | Integrated Core Strategies (US) LLC | 1,291,560 6.000% | -352,440![]() (-21.44%) | Filing History |
| 2026-11-02 5:08 pm Sale | 2026-09-30 | 13G | RXSIGHT INC RXST | Integrated Core Strategies (US) LLC | 2,142,052 5.100% | -888,235![]() (-29.31%) | Filing History |
| 2026-10-29 5:15 pm Sale | 2026-09-30 | 13G | ARES ACQUISITION CORP III AAC | Integrated Core Strategies (US) LLC | 1,555,000 3.900% | -550,000![]() (-26.13%) | Filing History |
| 2026-10-26 6:57 pm Sale | 2026-09-30 | 13G | APOLLO COMMERICAL REAL ESTATE ARI | Integrated Core Strategies (US) LLC | 4,686,105 3.600% | -2,058,813![]() (-30.52%) | Filing History |
| 2026-10-26 6:33 pm Sale | 2026-09-30 | 13G | LINCOLN INTL INC LCLN | Integrated Core Strategies (US) LLC | 722,900 2.000% | -1,306,517![]() (-64.38%) | Filing History |
| 2026-10-22 6:23 pm Sale | 2026-09-30 | 13G | NETSTREIT CORP NTST | Integrated Core Strategies (US) LLC | 3,932,143 3.100% | -1,314,583![]() (-25.06%) | Filing History |
| 2026-10-21 5:44 pm Sale | 2026-09-30 | 13G | LENZ THERAPEUTICS INC LENZ | Integrated Core Strategies (US) LLC | 1,159,987 3.700% | -443,525![]() (-27.66%) | Filing History |
| 2026-10-20 5:57 pm Purchase | 2026-10-13 | 13G | BLUE BIRD CORP COM BLBD | Integrated Core Strategies (US) LLC | 1,616,752 5.200% | 1,616,752![]() (New Position) | Filing History |
| 2026-10-20 5:40 pm Purchase | 2026-10-13 | 13G | WHIRLPOOL CORPORATION WHR | Integrated Core Strategies (US) LLC | 3,471,173 5.300% | 3,471,173![]() (New Position) | Filing History |
| 2026-10-19 5:54 pm Sale | 2026-09-30 | 13G | PHIBRO ANIMAL HEALTH CORPORATI PAHC | Integrated Core Strategies (US) LLC | 822,639 3.900% | -241,969![]() (-22.73%) | Filing History |
| 2026-10-15 5:28 pm Sale | 2026-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Integrated Core Strategies (US) LLC | 1,362,730 3.600% | -794,161![]() (-36.82%) | Filing History |
| 2026-10-14 5:14 pm Sale | 2026-09-30 | 13G | CAPRICOR THERAPEUTICS INC CAPR | Integrated Core Strategies (US) LLC | 1,669,083 2.900% | -1,274,003![]() (-43.29%) | Filing History |
| 2026-10-13 6:02 pm Sale | 2026-09-30 | 13G | IRHYTHM HLDGS INC IRTC | Integrated Core Strategies (US) LLC | 349,087 1.100% | -1,315,116![]() (-79.02%) | Filing History |
| 2026-10-13 4:55 pm Sale | 2026-09-30 | 13G | WW INTL INC WW | Integrated Core Strategies (US) LLC | 39,219 0.400% | -560,825![]() (-93.46%) | Filing History |
| 2026-10-13 4:53 pm Sale | 2026-09-30 | 13G | AMERESCO, INC. AMRC | Integrated Core Strategies (US) LLC | 29,686 0.100% | -1,786,483![]() (-98.37%) | Filing History |
| 2026-10-09 5:26 pm Purchase | 2026-09-30 | 13G | VANDA PHARMACEUTICALS INC VNDA | Integrated Core Strategies (US) LLC | 4,260,038 7.000% | 883,637![]() (+26.17%) | Filing History |

